MedPath

NEXBIOME THERAPEUTICS

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
phase_1_2
1 (50.0%)

Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection

Phase 1
Not yet recruiting
Conditions
Vulvovaginal Candidiasis
Bacterial Vaginosis
Interventions
Other: PLACEBO
First Posted Date
2024-06-10
Last Posted Date
2024-06-12
Lead Sponsor
NEXBIOME THERAPEUTICS
Target Recruit Count
165
Registration Number
NCT06450990

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.